Structural and biophysical characterization of novel GSK-3β inhibitors

Piretti, Valentina (2019) Structural and biophysical characterization of novel GSK-3β inhibitors, [Dissertation thesis], Alma Mater Studiorum Università di Bologna. Dottorato di ricerca in Scienze biotecnologiche e farmaceutiche, 31 Ciclo. DOI 10.6092/unibo/amsdottorato/9103.
Documenti full-text disponibili:
[img] Documento PDF (English) - Richiede un lettore di PDF come Xpdf o Adobe Acrobat Reader
Disponibile con Licenza: Salvo eventuali più ampie autorizzazioni dell'autore, la tesi può essere liberamente consultata e può essere effettuato il salvataggio e la stampa di una copia per fini strettamente personali di studio, di ricerca e di insegnamento, con espresso divieto di qualunque utilizzo direttamente o indirettamente commerciale. Ogni altro diritto sul materiale è riservato.
Download (3MB)

Abstract

The deregulation of GSK-3β (glycogen synthase kinase-3β) is involved in the pathogenesis of diverse diseases, such as cancer, diabetes and neurodegenerative disorders. Therefore, GSK-3β has become an attractive target for the design and development of new inhibitors for pathologies that present many limitations in therapeutic treatment. In the present thesis, we report a fast and efficient protocol for the expression of GSK-3β in insect cells with the baculovirus system, and employ purified GSK-3β in two different drug discovery projects. The first project describes the perspective validation of a novel computational method based on adiabatic bias molecular dynamics (ABMD) that aims to simulate protein-ligand unbinding events. Surface plasmon resonance (SPR) experiments performed on a series of GSK-3β inhibitors confirmed a coherence between predicted and experimental koff, highlighting the potential of this method for the calculation of residence times in hit-to-lead and lead optimization phases of drug discovery programs. Three novel X-ray crystal structures of pyrazine inhibitors in complex with GSK-3β are reported, providing further details in the binding mode of ATP-competitive GSK-3β inhibitors. The second project involves the structural and biophysical characterization of known GSK-3β allosteric inhibitors, and, in parallel, the discovery of novel allosteric modulators through computational and biophysical techniques. Herein, we describe the identification of promising molecules that have been selected by virtual screening and microscale thermophoresis (MST) analysis that display affinity to GSK-3β in the micromolar range. Taken together, our results provide useful insights for future rational drug design and discovery of small selective GSK-3β inhibitors.

Abstract
Tipologia del documento
Tesi di dottorato
Autore
Piretti, Valentina
Supervisore
Co-supervisore
Dottorato di ricerca
Ciclo
31
Coordinatore
Settore disciplinare
Settore concorsuale
Parole chiave
GSK-3β, drug discovery, allosteric inhibitors, baculovirus, SPR, crystallography, MST, molecular dynamics, NMR
URN:NBN
DOI
10.6092/unibo/amsdottorato/9103
Data di discussione
28 Ottobre 2019
URI

Altri metadati

Statistica sui download

Gestione del documento: Visualizza la tesi

^